CRISPR cancer trial success paves the way for personalized treatments
Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies.
・ From Nature
Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies.
・ From Nature